588 related articles for article (PubMed ID: 9550628)
1. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
[TBL] [Abstract][Full Text] [Related]
2. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
Schmieder RE; Schlaich MP
Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
[TBL] [Abstract][Full Text] [Related]
5. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of left ventricular hypertrophy by antihypertensive drugs.
Fagard RH
Neth J Med; 1995 Oct; 47(4):173-9. PubMed ID: 8538821
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
Dahlöf B
Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
[TBL] [Abstract][Full Text] [Related]
8. Hypertension: are beta-blockers and diuretics appropriate first-line therapies?
Wilson MD; Weart CW
Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
Fagard RH; Celis H; Thijs L; Wouters S
Hypertension; 2009 Nov; 54(5):1084-91. PubMed ID: 19770405
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
[No Abstract] [Full Text] [Related]
11. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
[TBL] [Abstract][Full Text] [Related]
12. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
16. Regression of left ventricular hypertrophy--a meta-analysis.
Dahlöf B; Pennert K; Hansson L
Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents.
Schlaich MP; Schmieder RE
Am J Hypertens; 1998 Nov; 11(11 Pt 1):1394-404. PubMed ID: 9832187
[TBL] [Abstract][Full Text] [Related]
18. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
[TBL] [Abstract][Full Text] [Related]
19. [Therapy for hypertension associated with heart failure].
Miyamoto H; Imaizumi T
Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
[No Abstract] [Full Text] [Related]
20. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
